As a physician, Brian Koffman, MDCM, DCFP, DABFM, MS Ed, medical director, CLL Society, was able to leverage his medical and scientific knowledge during treatment for his chronic lymphocytic leukemia (CLL), and he encourages other patients to educate themselves on their illnesses in order to receive the best care.
As a physician, Brian Koffman, MDCM, DCFP, DABFM, MS Ed, medical director, CLL Society, was able to leverage his medical and scientific knowledge during treatment for his chronic lymphocytic leukemia (CLL), and he encourages other patients to educate themselves on their illnesses in order to receive the best care.
Transcript
As a doctor, but not a hematologist/oncologist, what was it like to become a patient diagnosed with CLL?
I think as a physician when you’re diagnosed with a life-changing cancer such as CLL, you have an extra responsibility and burden because you can see further, you can see around the corners. So, I took that burden and wanted to sort of come out of the closet and share my journey. That was my personal response. I became very public about my CLL, and it was at a time that CLL treatments were changing radically, and it allowed me to share my experience and sort of give forward so people could benefit from what I had been through, what mistakes I’d made, what good choices I’d made, and learn from that.
When you’re a physician, often the other physicians assume that you know what’s going on. But I’d often ask them to stop and say, “Hey, explain to me as if I’m an ordinary patient. I’m not a hematologist/oncologist, let me see if I can understand this and know what’s going on.” So, I think that that’s another piece that you need to be involved in.
Our motto [at the CLL Society] is “smart patients get smart care,” so I think it’s really critical to educate yourself. And you don’t have to be a physician to educate yourself. You can learn the information and then share it with your treatment team and say, “Hey, does this make sense for me? Does this apply here?” So, that’s the kind of thing that I push. It’s easier for me as a doctor to read those articles. It’s easier to understand the medical conferences stuff. So, I use all of that to leverage and I think every patient has to leverage whatever advantages they have. And I use my scientific medical knowledge and that’s why I enrolled in 2 very early trials, which were life-saving for me.
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More